Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
FEBS Letters|September 3, 1990
The C-terminal binding domain of hirullin P18. Antithrombin activity and comparison to hirudin peptidesJ L Krstenansky, T J Owen, M T Yates, et al.Journal of Medicinal Chemistry|May 1, 1988
N-terminal requirements of small peptide anticoagulants based on hirudin54-65T J Owen, J L Krstenansky, M T Yates, et al.FEBS Letters|January 2, 1989
Short model peptides having a high alpha-helical tendency: design and solution propertiesJ L Krstenansky, T J Owen, K A Hagaman, et al.The Biochemical Journal|July 1, 1993
An echistatin C-terminal peptide activates GPIIbIIIa binding to fibrinogen, fibronectin, vitronectin and collagen type I and type IVP S Wright, V Saudek, T J Owen, et al.FEBS Letters|January 20, 1992
Specific inhibition of binding of antistasin and [A103,106,108] antistasin 93-119 to sulfatide (Gal(3-SO4)beta 1-1Cer) by glycosaminoglycansR G Brankamp, G D Manley, T J Owen, et al.Biochimica Et Biophysica Acta|February 10, 1993
Amphipathic alpha-helical peptides based on surfactant apoprotein SP-AL R McLean, J E Lewis, K A Hagaman, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Centrally truncated and stabilized porcine neuropeptide Y analogs: design, synthesis, and mouse brain receptor bindingJ L Krstenansky, T J Owen, S H Buck, et al.Biochemistry|October 17, 1989
Effect of micelle diameter on tryptophan dynamics in an amphipathic helical peptide in phosphatidylcholineL R McLean, J L Krstenansky, T J Owen, et al.Advances in Experimental Medicine and Biology|January 1, 1992
Heparin binding properties of the carboxyl terminal domain of [A103,106,108] antistasin 93-119G D Manley, T J Owen, J L Krstenansky, et al.Rapid Communications in Mass Spectrometry : RCM|April 1, 1992
Evidence for a lysine-specific fragmentation in fast-atom bombardment mass spectra of peptidesB L Ackermann, R J Barbuch, J E Coutant, et al.Pageof 3